BURSTANALYSE

European patent · EP3071102 · In force

Register entry

Publication number
EP3071102
Application number
EP14864081
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 20, 2014
Published
Sep 28, 2016
Granted
Sep 17, 2025
Protection ends at the latest
Nov 19, 2034
Next annual fee due
Nov 30, 2026
IPC classes
A61B 5/00 (2006.01)
A61B 5/316 (2021.01)
A61B 5/369 (2021.01)
A61B 5/145 (2006.01)
Priority
AU 2013904486 20.11.2013
PCT application
PCT/AU2014/050364 20.11.2014
PCT publication
WO2015/074116 28.05.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 29, 2026

    Change

    Published in Swissreg on 29.07.2026

  2. Dec 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.11.2025 → 30.11.2026

    Published in Swissreg on 01.12.2025

  3. Nov 26, 2025

    Agent entered

    Representative
    Murgitroyd & Company, Geneva Rhone 8 Sàrl, Rue du Commerce 4, 1204 Genève

    Published in Swissreg on 26.11.2025

  4. Sep 17, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 17.09.2025

Parties

Holder

THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH

The Brancroft Centre 300 Herston Road, Herston, QLD 4029, AU

Agent

Murgitroyd & Company

Geneva Rhone 8 Sàrl Rue du Commerce 4, 1204 Genève

Inventor

BREAKSPEAR, Michael

Herston, Queensland 4006, AU

ROBERTS, James

Herston, Queensland 4006, AU

VANHATALO, Sampsa

00430 Helsinki, FI

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.